Brigham expands hosting of student trainees through a new partnership
Bloomberg Philanthropies committed $37.8 million to Mass General Brigham to create a new healthcare career preparatory curriculum at the Edward M. Kennedy Academy of Health Careers School
Read more
All News & Stories
Showing 11 - 20 of 228 stories
Help Us Improve Brain Health
Support innovative work to transform brain disease prevention and treatment
SPORE Collaboration Plants the Seed for Cancer Drug Approval
This spring, in the latest example of success that has emerged from the SPORE, the Food and Drug Administration granted accelerated approval of the oral drug tovorafenib.
Stroke Patient Makes Full Recovery Thanks to the Brigham
Bonnie Slater-Demont shares her gratitude for making a full recovery. "Thank God for the Brigham."
Study Finds Ketamine Is at Least as Effective as ECT for Treating Major Depression
Major Depressive Disorder (MDD) is a leading cause of disability worldwide and is estimated to affect 21 million adults in the United States.
Parkinson’s Disease Therapies: Genomic Insights and Stem-Cell Innovations
Both genetic and environmental factors cause Parkinson’s disease. The overarching goal is to develop patient-tailored therapies to prevent or slow down the disease.
Stay connected.
Join our email list to get updates sent right to your inbox.
Form submitted successfully, thank you!
Alzheimer’s and Family History
Maternal Inheritance of Alzheimer’s Disease Tied to Increased Risk of Developing Disease
Parkinson’s Disease Diet
Lifestyle changes such as eating well, exercising, and reducing stress can also help with Parkinson’s disease.
Innovations in Brain Research and Care
Brigham experts pioneer new approaches to treating brain diseases
